Hypothetical explanation of the embryotoxic action of thalidomide.
D000818:Animals; D001205:Ascorbic Acid; D003094:Collagen; D004622:Embryo, Mammalian / Q000187:drug effects*; D004625:Embryo, Nonmammalian; D005260:Female; D007527:Isoenzymes / Q000037:antagonists & inhibitors; D007656:Ketoglutaric Acids; D006899:Mixed Function Oxygenases / Q000037:antagonists & inhibitors*; D011247:Pregnancy; D011392:Proline; D013792:Thalidomide / Q000008:administration & dosage / Q000633:toxicity*
D007527:Isoenzymes; D007656:Ketoglutaric Acids; D013792:Thalidomide; D003094:Collagen; D011392:Proline; D006899:Mixed Function Oxygenases; D001205:Ascorbic Acid